Product Information
ONDANSETRON ODT 4 MG TABLET is a generic product labeled by Ipca Laboratories Limited, priced at $0.1199 per EA under NDC 83980001213. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Oct 30, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Ipca Laboratories LimitedNDC
83980001213
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRONApproval Type
Generic (ANDA)
FDA Application
ANDA209389FDA Approved
10/30/2023
TE Code
AB
On Market Since
6/19/2025
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON ODT 4 MG TABLET has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per EA |
|---|---|
| All-time high | $0.1631 (Oct 15, 2025) |
| All-time low | $0.1199 (Sep 23, 2026) |
| 52-week high | $0.1631 |
| 52-week low | $0.1199 |
| Median price | $0.1501 |
| Average price | $0.1428 |
| Largest weekly change | -6.8% (Apr 22, 2026) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ipca Laboratories Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON ODT 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON ODT 4 MG TABLET, manufactured by Ipca Laboratories Limited, is $0.1199 per EA (NDC 83980001213), effective Sep 30, 2026.
How has the price of ONDANSETRON ODT 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON ODT 4 MG TABLET has declined 26.5%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for ONDANSETRON ODT 4 MG TABLET?
Since Oct 1, 2025, the NADAC for ONDANSETRON ODT 4 MG TABLET has ranged from a low of $0.1199 (Sep 23, 2026) to a high of $0.1631 (Oct 15, 2025), with a median of $0.1501 per EA.
Are there cheaper alternatives to ONDANSETRON ODT 4 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON HCL 4 MG TABLET, is $0.0582 per EA — about 51% below ONDANSETRON ODT 4 MG TABLET.
Who manufactures ONDANSETRON ODT 4 MG TABLET?
ONDANSETRON ODT 4 MG TABLET (NDC 83980001213) is labeled by Ipca Laboratories Limited, and CMS classifies it as a generic product.